HALOZYME THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Halozyme Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Halozyme Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 127M shares, a 3.71% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 127M -4.9M -3.71% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 127M -5.32M -4.04% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 127M -4.48M -3.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 127M -8.38M -6.2% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 132M -3.13M -2.32% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 132M -5.83M -4.23% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 132M -6.23M -4.52% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 135M -2.34M -1.71% Dec 31, 2022 10-K 2024-02-20
Q3 2022 135M -5.76M -4.08% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 138M -4.5M -3.17% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 138M -5.49M -3.83% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 137M +2.47M +1.83% Dec 31, 2021 10-K 2023-02-21
Q3 2021 141M +5.6M +4.13% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 142M +5.51M +4.03% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 143M +8.02M +5.92% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 135M -1.68M -1.23% Dec 31, 2020 10-K 2022-02-22
Q3 2020 135M -11.1M -7.57% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 137M -9.19M -6.3% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 135M -10M -6.88% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 137M -8.01M -5.54% Dec 31, 2019 10-K 2021-02-23
Q3 2019 146M +1.94M +1.34% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 146M +1.64M +1.14% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 145M +1.48M +1.03% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 145M +1.94M +1.36% Dec 31, 2018 10-K 2020-02-24
Q3 2018 145M +2.22M +1.56% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 144M +2.31M +1.63% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 144M +14.1M +10.8% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 143M +13.3M +10.3% Dec 31, 2017 10-K 2019-02-21
Q3 2017 142M +12.8M +9.9% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 142M +12.5M +9.66% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 130M +708K +0.55% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 130M +1.35M +1.05% Dec 31, 2016 10-K 2018-02-20
Q3 2016 129M +1.68M +1.31% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 129M +1.65M +1.29% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 129M +1.95M +1.53% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 128M +2.43M +1.93% Dec 31, 2015 10-K 2017-02-28
Q3 2015 128M +2.27M +1.8% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 128M +2.47M +1.97% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 127M +2.68M +2.15% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 126M +11.2M +9.77% Dec 31, 2014 10-K 2016-02-29
Q3 2014 126M +11.6M +10.1% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 125M +12M +10.6% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 124M +11.3M +10% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 115M +1.82M +1.62% Dec 31, 2013 10-K 2015-03-02
Q3 2013 114M +1.29M +1.15% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 113M +597K +0.53% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 113M +732K +0.65% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 113M +8.72M +8.39% Dec 31, 2012 10-K 2014-02-28
Q3 2012 113M +9.04M +8.73% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 113M +9.08M +8.76% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 112M Mar 31, 2012 10-Q 2012-05-07
Q4 2011 104M +3.41M +3.39% Dec 31, 2011 10-K 2013-03-01
Q3 2011 104M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 104M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 101M Dec 31, 2010 10-K 2012-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.